Tag: ARIA
Lilly’s Donanemab gets CDSCO approval
Eli Lilly and Company has announced that the Central Drugs Standard Control Organization (CDSCO) has granted marketing authorization for donanemab (350 mg/20 mL administered...
This function has been disabled for HealthTekPack.